presents

Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Associations 35th International Symposium on ALS/MND

BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing…

2 weeks ago

MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND

December 05, 2024 18:00 ET | Source: MediciNova, Inc. LA JOLLA, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc.,…

2 weeks ago

OPPI Annual Summit Presents the Roadmap on Becoming the Pharma Powerhouse to the World

This year's Summit theme, 'Viksit Bharat@2047', envisions India's journey from the Pharmacy of the World to a Global Pharma Powerhouse,…

3 weeks ago

OPPI Annual Summit Presents the Roadmap on Becoming the Pharma Powerhouse to the World

This year's Summit theme, 'Viksit Bharat@2047', envisions India's journey from the Pharmacy of the World to a Global Pharma Powerhouse,…

3 weeks ago

OPPI Annual Summit Presents the Roadmap on Becoming the Pharma Powerhouse to the World

This year's Summit theme, 'Viksit Bharat@2047', envisions India's journey from the Pharmacy of the World to a Global Pharma Powerhouse,…

3 weeks ago

OPPI Annual Summit Presents the Roadmap on Becoming the Pharma Powerhouse to the World

This year's Summit theme, 'Viksit Bharat@2047', envisions India's journey from the Pharmacy of the World to a Global Pharma Powerhouse,…

3 weeks ago

OPPI Annual Summit Presents the Roadmap on Becoming the Pharma Powerhouse to the World

This year's Summit theme, 'Viksit Bharat@2047', envisions India's journey from the Pharmacy of the World to a Global Pharma Powerhouse,…

3 weeks ago

OPPI Annual Summit Presents the Roadmap on Becoming the Pharma Powerhouse to the World

This year's Summit theme, 'Viksit Bharat@2047', envisions India's journey from the Pharmacy of the World to a Global Pharma Powerhouse,…

3 weeks ago

Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)

Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC.Updated results of…

4 weeks ago

Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)

Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC.Updated results of…

4 weeks ago
Show more Posts
Show previous Posts